Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A new paper published on line in the Journal of Urology suggests that the PSA and %free PSA levels of current smokers and former smokers may be statistically significantly impacted compared to those of men who have very rarely or never smoked.
Filed under: Diagnosis, Risk | Tagged: free, history, PSA, smoking, total | 1 Comment »
New data from a research team at Stanford University in California have further confirmed the effect of “heavy” smoking on the diagnosis of men with prostate cancer.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: radical prostatecomy, recurrence, smoking | 1 Comment »
New data from the Health Professionals Follow-Up Study (HPFUS) suggest that men who are smokers at the time of diagnosis of prostate cancer are at increased risk for prostate cancer progression or recurrence and prostate cancer-specific mortality compared to those who have never smoked or who stopped at least 10 years earlier.
Filed under: Diagnosis, Living with Prostate Cancer, Risk, Uncategorized | Tagged: mortality, recurrence, risk, smoking | 1 Comment »
In today’s news reports from sources other than the ASTRO meeting, we note items dealing with: PSA bounce in brachytherapy patients Fatal prostate cancer and a history of smoking Ketoconazole + dutasteride in treatment of CRPC
Filed under: Management, Prevention, Risk, Treatment | Tagged: Avodart, brachytherapy, castration-resistant prostate cancer, CRPC, dutasteride, ketoconazole, PSA bounce, smoking | 1 Comment »
In today’s news reports we cover items on: Risks for prostate cancer from smoking and increased adipose tissue The role of religious activities in prostate cancer testing among African Americans Blood loss at the time of surgery and risk for progressive disease
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: adipose, blood loss, BMI, body mass index, DRE, ethnicity, recurrence, religion, risk, smoking | Leave a Comment »
Today’s news reports address: Smoking and risk for prostate cancer Assessing risk for a positive second biopsy after a prior negative biopsy Smoking pot won’t cure your cancer but … Pemetrexed not effective as a single agent in CRPC patients after docetaxel failure
Filed under: Diagnosis, Drugs in development, Management, Prevention, Risk, Treatment, Uncategorized | Tagged: biopsy, canabis, castration-resistant prostate cancer, CPRC, pemetrexed, pot, risk, smoking | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site